Diabetic kidney disease (DKD) and peripheral vascular disease (PVD) are two major complications that are frequently encountered in T2DM patients. The purpose of this study was to examine the potential ability of miRNA-21 as a biomarker for detecting new cases of T2DM as well as identifying those with T2DM and DKD or PVD.
(2022). Plasma MicroRNA-21 in Patients with Type 2 Diabetes Mellitus and Its Correlation with Albuminuria and Cardiometabolic Risk. Egyptian Society of Diabetes and Lipidology Journal, 2(2), -. doi: 10.21608/esdlj.2022.455802
MLA
. "Plasma MicroRNA-21 in Patients with Type 2 Diabetes Mellitus and Its Correlation with Albuminuria and Cardiometabolic Risk", Egyptian Society of Diabetes and Lipidology Journal, 2, 2, 2022, -. doi: 10.21608/esdlj.2022.455802
HARVARD
(2022). 'Plasma MicroRNA-21 in Patients with Type 2 Diabetes Mellitus and Its Correlation with Albuminuria and Cardiometabolic Risk', Egyptian Society of Diabetes and Lipidology Journal, 2(2), pp. -. doi: 10.21608/esdlj.2022.455802
VANCOUVER
Plasma MicroRNA-21 in Patients with Type 2 Diabetes Mellitus and Its Correlation with Albuminuria and Cardiometabolic Risk. Egyptian Society of Diabetes and Lipidology Journal, 2022; 2(2): -. doi: 10.21608/esdlj.2022.455802
)
